| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023459576 |
| P356 | DOI | 10.1038/SREP10198 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep10198 |
| P932 | PMC publication ID | 4431468 |
| P698 | PubMed publication ID | 25974028 |
| P5875 | ResearchGate publication ID | 276295836 |
| P50 | author | Elaine Holmes | Q28469525 |
| Muhammad Saeed Ahmad | Q79828821 | ||
| P2093 | author name string | Hala H Mosli | |
| Torben Kimhofer | |||
| Zoheir A Damanhouri | |||
| P2860 | cites work | Simple non-invasive assessment of advanced glycation endproduct accumulation | Q28271097 |
| Protein glycation, diabetes, and aging | Q32120059 | ||
| Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis | Q33542625 | ||
| Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. | Q33563689 | ||
| Growing epidemic of coronary heart disease in low- and middle-income countries | Q33828135 | ||
| GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence | Q33839324 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetes | Q34764344 | ||
| Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study | Q35071085 | ||
| Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases | Q35753534 | ||
| Role of advanced glycation end products in cardiovascular disease. | Q35929112 | ||
| Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects | Q35946402 | ||
| Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. | Q35985860 | ||
| Advanced glycation endproducts--role in pathology of diabetic complications | Q35994161 | ||
| Advanced glycation end products measured by skin autofluorescence in a population with central obesity | Q36130015 | ||
| Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases | Q37002833 | ||
| Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes | Q37022709 | ||
| Ethnic and gender differences in advanced glycation end products measured by skin auto-fluorescence | Q37170341 | ||
| Obesity and cardiovascular outcomes: a review | Q38187956 | ||
| Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue | Q39797009 | ||
| Reference values of skin autofluorescence | Q39883440 | ||
| Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence. | Q42120056 | ||
| Advanced glycation end products in children with type 1 diabetes: family matters? | Q43019527 | ||
| Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients | Q43444061 | ||
| Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients. | Q43549300 | ||
| Lens ageing as an indicator of tissue damage associated with smoking and non-enzymatic glycation--a twin study | Q44178350 | ||
| Comparison of vitamin D deficiency in Saudi married couples | Q44401984 | ||
| Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease | Q45140048 | ||
| Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus | Q45351757 | ||
| Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population. | Q45970190 | ||
| Serum 25 hydroxyvitamin D in employees of a Middle Eastern university hospital. | Q45982770 | ||
| Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy | Q46602167 | ||
| Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine | Q46613227 | ||
| Skin autofluorescence as a biological UVR dosimeter | Q47248692 | ||
| Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients. | Q51027112 | ||
| Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration. | Q51029718 | ||
| Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia. | Q51044230 | ||
| Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years. | Q51047910 | ||
| Skin color independent assessment of aging using skin autofluorescence. | Q51678716 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease | Q82005957 | ||
| Dermal factors influencing measurement of skin autofluorescence | Q83338712 | ||
| Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes | Q84094406 | ||
| Total antioxidant status before and after bariatric surgery for type 2 diabetes mellitus | Q84215879 | ||
| Skin autofluorescence is elevated in neovascular age-related macular degeneration | Q84510537 | ||
| P2507 | corrigendum / erratum | Corrigendum: A new gender-specific model for skin autofluorescence risk stratification | Q42210698 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10198 | |
| P577 | publication date | 2015-05-14 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A new gender-specific model for skin autofluorescence risk stratification | |
| P478 | volume | 5 |
| Q37622708 | A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness. |
| Q59126439 | Characterization of human cutaneous tissue autofluorescence: implications in topical drug delivery studies with fluorescence microscopy |
| Q41899840 | Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus |
| Q42210698 | Corrigendum: A new gender-specific model for skin autofluorescence risk stratification | main subject | P921 |
Search more.